Please reload

Recent Posts

Virtuvax for collaboration on your innovation in vaccine development or your biosimilar

May 12, 2017

Please reload

Featured Posts

SynGEM publication paper of the month on ReSViNET

April 5, 2019

#ReSViNET , the Respiratory Syncytial Virus Network, selected the recent publication in AJRCCM on the SynGEM Phase I clinical trial as paper of the month March. The study which was executed by Imperial College London, showed that #SynGEM is safe and capable of inducing long term immune responses. A commentary published in the same journal suggested to test the vaccine in a human challenge study. The author manuscript can now be downloaded free of charge from the ReSViNET website

Please reload

Follow Us